Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramlintide Acute Effect on Satiety and Food Intake
NCT00042601Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Jul 2002
- Primary completion
- Oct 2003
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of pramlintide in type 1 diabetes mellitus (T1D), type 2 diabetes mellitus (T2DM), obesity, sponsored by AstraZeneca. Started Jul 2002; status: completed.
02
Drugs
pramlintide
03
Conditions
type 1 diabetes mellitus (T1D)type 2 diabetes mellitus (T2DM)obesity
Beyond the preview
Go deeper on NCT00042601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00042601.